$MGPI

MGP Ingredients reports mixed Q3 results; reaffirms FY26 outlook

MGP Ingredients reported Q3 Non-GAAP EPS of $0.39, beating estimates by $0.07. Revenue fell 9.9% year-over-year to $117.9M, missing expectations. Adjusted EBITDA declined 33% to $21.5M. The company reaffirmed its FY26 outlook despite these results.

Original reporting
Published Oct 28, 2026, 11:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$MGPI
Neutral
medium confidence
Mentioned
$MGPI
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$MGPINeutralMed
01

Why it matters

For traders, the key tension is EPS outperformance versus deteriorating revenue and adjusted EBITDA, plus cash outflows, which can drive valuation debate even with guidance reaffirmation.

02

Market read

A mixed earnings print with reaffirmed long-term outlook can still shift near-term positioning due to EBITDA contraction and cash outflows.

03

What to watch

The Penelope earnout inclusion in operating cash outflows may distort cash-flow optics; traders may need to separate earnout-related cash movements from underlying working-capital trends.

Relevance 7/10Novelty 6/10Timing: post-Q3 earnings release, traders digest results and reaffirmed FY26 outlook

Background

The piece summarizes MGPI’s Q3 performance versus expectations and notes operating cash outflows tied partly to the Penelope earnout, while reaffirming FY26 guidance.

Company-level read

Ticker impact

$MGPINeutralMedium confidence
Context

MGPI reported Q3 non-GAAP EPS of $0.39 that beat estimates, but revenue fell 9.9% Y/Y and adjusted EBITDA dropped 33%.

Expected impact

Shares may face choppy trading, with upside limited by revenue decline, EBITDA contraction, and operating cash outflows.

Evidence & confidence

The article provides both upside (EPS beat) and downside (revenue miss, EBITDA down 33%, operating cash outflows) plus a reaffirmed FY26 outlook, which can offset but not fully negate the operational deterioration.

Market effects

Signals ongoing margin and cash-flow pressure risk in food ingredients/specialty nutrition supply chains, despite earnings resilience.

No clear regional spillover indicated beyond US-listed issuer sentiment.

Limited global read-through; impacts are primarily company-specific unless peers show similar margin/cash stress.

Counterpoint

The EPS beat and reaffirmed FY26 outlook could indicate temporary cost timing or non-recurring items, making the EBITDA and cash outflow weakness less predictive.

Key entities

  • MGP Ingredients

    US-listed food ingredients company reporting mixed Q3 results and reaffirming FY26 outlook.

  • Penelope earnout

    Earnout component included in year-to-date operating cash outflows, affecting cash-flow optics.

Related articles

$MGPIMed

MGP Ingredients Reports Q3 Sales of $117.9 Million, Reaffirms 2026 Outlook

MGP Ingredients reported Q3 2026 sales of $117.9M, down 10% YoY, with net income of $6.9M. Adjusted EPS was $0.39, down from $0.85. The company reaffirmed its 2026 outlook and announced a name change to Sempreon on November 2. Sales growth was seen in Penelope Bourbon and mid-priced brands, while Distilling Solutions faced market challenges. Ingredient Solutions saw growth in specialty wheat proteins.

$MGPIMed

MGP Ingredients Reports Third Quarter 2026 Results

MGP INGREDIENTS INC (MGPI) filed an SEC Form 8-K — Results of Operations and Financial Condition. MGP Ingredients Reports Third Quarter 2026 Results Company reaffirms full-year 2026 guidance, declares $0.12 quarterly dividend and will become Sempreon, Inc. (Nasdaq: CASK) on November 2 ATCHISON, Kan., October 28, 2026 - MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider

$MGPIMedAI 8/10

A bourbon brand's sales rose 12% as MGP Ingredients' total sales fell 10%.

MGP Ingredients reported a 10% decline in total sales for Q3 2026, with Branded Spirits sales down 4% and Distilling Solutions sales down 29%. Penelope Bourbon sales rose 12%. Gross profit fell 18% to $40.5M. The company reaffirmed its 2026 guidance, expecting sales of $480M-$500M and adjusted EBITDA of $82M-$90M. MGP will change its name to Sempreon, Inc. and ticker to CASK on November 2, 2026.

$TSNHigh

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills Shares Are Falling, What You Need To Know

Tyson Foods, MGP Ingredients, Conagra, Flowers Foods, and General Mills shares fell due to U.S. cattle shortages and margin pressures. Tyson cut its 2026 adjusted operating income outlook to $2.1B-$2.3B, citing beef-segment losses. The company is closing plants and exploring sales to restructure. Other firms also saw declines. Tyson's stock is down 11% YTD and 24.8% from its 52-week high.